The study identifies a novel ABCA1-dependent high-capacity binding site for apoA-I at the plasma membrane, providing a biochemical basis for a two-site model of HDL biogenesis.
No takes yet. Share an insight, caveat, or question.
New apoA-I binding site identified in fibroblasts; hypothesis-generating for HDL biogenesis with no immediate clinical implications.
Hassan et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: